Abstract-In patients with hypertension, but without established cardiovascular disease, predictive factors for sudden cardiac death (SCD) remain undefined. We followed for an average of 10.3 years a cohort of 3242 initially untreated hypertensive patients without evidence of coronary or cerebrovascular heart disease at entry. All patients underwent a complete clinical examination which included ECG and 24-hour ambulatory blood pressure monitoring. At entry, the mean age of patients was 50.0 years, 45% were women, and 6.1% had type 2 diabetes mellitus. Average office blood pressure was 154/96 mm Hg, and average 24-hour ambulatory blood pressure was 136/86 mm Hg. Prevalence of left ventricular hypertrophy at ECG was 13.9%. During follow-up, SCD occurred in 33 patients at a rate of 0.10 per 100 patient-years (95% CI, 0.07-0.14). 
A bout 50% of deaths because of cardiovascular causes are sudden. 1 Sudden cardiac death (SCD) is an emerging public health priority because it accounts for up to 375 000 deaths per year in United States, with an overall incidence of 0.1% to 0.2% per year. 2, 3 Similar rates have been reported in Europe. 4 Thus, although the incidence of SCD is relatively low in the general population, the absolute numbers are high. The interest for SCD increased over the past few years, as evidence accumulated that implantable and external cardioverter defibrillators reduce mortality for SCD in high-risk patients. 5 Among the established predictors of SCD, 5 hypertension plays an important role. [6] [7] [8] [9] Studies with 24-hour ECG monitoring have found a higher frequency of ventricular ectopic activity and complex cardiac arrhythmias in patients with hypertension, [10] [11] [12] which could predispose to SCD. Studies in mixed populations with and without hypertension, coronary artery disease, valvular heart disease, and heart failure have found an association between left ventricular hypertrophy (LVH) and the risk of ventricular tachycardia/fibrillation 13 and SCD. [14] [15] [16] [17] [18] [19] [20] A direct relation has been found in the general population between echocardiographic LV mass and the risk of SCD. 14, 16 Although the above-mentioned studies tried to establish the independent relation between LVH and SCD through sophisticated statistical adjustments for coexisting coronary artery disease, heart failure, and valvular heart disease, no epidemiological studies are available on the independent impact of LVH on the risk of SCD in wide populations of patients with hypertension initially free of established cardiac or cerebrovascular disease. Thus, the prognostic impact of LVH as potential predictor of SCD in this wide stratum of the hypertensive population remains unknown. Similarly, despite the evidence that 24-hour ambulatory blood pressure (BP) is superior to office BP for cardiovascular risk stratification, [21] [22] [23] the relation between ambulatory BP and the risk of SCD remains unknown.
Methods
The Progetto Ipertensione Umbria Monitoraggio Ambulatoriale was established in June 1986. Details of the study have been published. 23, 24 In brief, it is a prospective observational registry of morbidity and mortality in initially untreated patients with hypertension (absence of previous antihypertensive treatment or treatment having been withdrawn for at least 4 weeks). The registry was approved by the Local Ethics Committee of the Italian National Health Service, and all subjects provided their informed consent to participate. The data that support the findings of this study are available from the corresponding author on reasonable request.
We excluded patients with secondary causes of hypertension, previous cardiovascular disease, or life-threatening disorders. BP was measured by a physician with a mercury sphygmomanometer with subjects sitting and relaxed for at least 10 minutes. Cuff size was adjusted to arm circumference. Three measurements were averaged for analysis. Systolic and diastolic BP were identified by Korotkoff phases I and V.
Ambulatory BP
We recorded ambulatory BP by using an oscillometric device (SpaceLabs 520016, 9020217 and 9020718; SpaceLabs, Redmond, WA) and set the frequency of measurements to one every 15 minutes throughout the 24 hours. We assessed the reproducibility of ambulatory BP readings in our subjects in a previous study, in which a random sample of untreated hypertensive subjects included in the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale registry repeated 24-hour BP monitoring within 3 to 5 days. 25 The betweensession coefficient of variability (SD of the mean of the paired differences between 2 sessions divided by the average of all paired means) was 5.9%/6.3% for daytime BP and 6.1%/6.3% for nighttime BP. 25 Twenty-four hour pulse pressure (PP) was defined as the difference between systolic and diastolic BP over the 24-hour recording period.
Electrocardiography
All patients underwent a 25-mm/s 12-lead ECG at entry. We defined LVH diagnosis by ECG in a binary (yes or no) fashion by one or both of the following: (1) sum of the R wave in lead aVL and depth of the S wave in lead V 3 >2.0 mV in women and >2.4 mV in men and (2) strain pattern in at least one of the following leads: I, II, aVL, or V 4 to V 6 . Strain pattern was considered present if there was ST-segment depression of at least 0.5 mm and inverted T wave in any of the aforementioned leads in the direction opposite the polarity of the QRS. The above definition of LVH may be detected through simple visual inspection of ECG tracings. It is reproducible 26 and applicable to large study cohorts. 27 In a large validation study in patients with hypertension, it yielded 34% sensitivity and 91% specificity with echocardiographic LVH as reference and identified subjects at increased risk of major cardiovascular events with a greater population-attributable risk (16.1%) when compared with traditional ECG criteria of LVH. 28 We diagnosed diabetes mellitus by a fasting plasma glucose of ≥7.0 mmol/L (126 mg/dL) or current antidiabetic therapy.
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Follow-Up
We tailored treatment on an individual basis by using lifestyle and pharmacological measures. Follow-up of patients was in charge of family doctors, in collaboration with our hospital staff. We planned periodical contacts with family doctors and phone interviews and clinical visits with patients to ascertain the vital status and the occurrence of events.
Assessment of End-Points
We reviewed in conference all hospital records and other source documents of patients with presumed SCD. Events were adjudicated by the authors of this study. According with Guidelines, we defined SCD as an unexpected and sudden pulseless situation of presumed underlying cardiac origin because of the absence of conditions clearly unrelated to cardiac arrhythmias (ie, death during a car accident or associated with cancer, acute stroke, pneumonitis, pulmonary embolism, massive blood loss, myocardial rupture after myocardial infarction).
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Data Analysis
Data analysis was performed using SAS/Stat release 14.3 (SAS Institute, Inc, http://www.sas.com) and the R software 3.5.2. (R Foundation for Statistical Computing, http://www.R-project.org). We reported parametric data as mean±SD. The distribution of clinical characteristics at entry between patients with and without subsequent SCD was made using the Student t test and the χ 2 test. On the basis of current literature, we identified a parsimonious set of covariables potentially related to the occurrence of SCD in patients with hypertension. These included age, sex, diabetes mellitus, and LVH. Unadjusted event-free survival was assessed with Kaplan-Meier curves and compared using weighted log-rank tests to account for the expected low number of events relative to the sample size at the study end point. 30 In the presence of a low number of number of events per variable, multivariable modeling can be troublesome, 31 but instability of the estimated regression coefficients and sparse data bias can be reduced by maximizing the penalized partial log-likelihood. 32 Firth penalized likelihood approach 33 is recommended because it has been shown to reduce bias in parameter estimates on data with rare events. 34 Hence, to minimize potential bias because of a low events per variable, we fitted multivariable Cox models and derived hazard ratios with profile likelihood 95% CIs and corresponding P values, using Firth penalized partial likelihood method. 33, 34 We then included into the model selected ambulatory BP components, of proven prognostic relevance, to evaluate the possible impact of BP as a continuous variable on the study outcome. We identified average 24-hour PP as an added predictor because on examining multivariable survival models with different ambulatory BP components (ie, 24-hour systolic BP, 24-hour diastolic BP, 24-hour PP), only 24-hour PP reached formal statistical significance (P=0.036). Besides, the choice was also made in view of 24-hour PP superiority over office PP in refining cardiovascular risk stratification in large cohorts of patients with hypertension. [35] [36] [37] [38] To estimate the impact of modifiable risk factors on the incidence of SCD, we calculated the population-attributable fraction as P×([adjusted hazard ratio−1]/adjusted hazard ratio), where P is the proportion of cases with the risk factor. 39 Finally, to evaluate the model discrimination ability, we calculated the model overall C statistics and a time-dependent receiver operating characteristic curve at 10 years according to Uno et al. 40 Two-sided P values ≤0.05 were considered statistically significant. Figure 1 shows the flow diagram of the study. Out of 3907 individuals enrolled between June 1986 and March 2010, we selected for the present study 3808 patients with office hypertension. 41 After exclusion of 289 patients with missing follow-up information and 277 patients with ECG unavailable or unsuitable for LVH assessment because of complete right or left bundlebranch block, preexcitation syndrome, or pathological Q waves (≥0.04 second in duration), 3242 patients entered the study. As shown in Table 1 , the mean age of patients was 50.0 years, prevalence of type 2 diabetes mellitus was 6.1%, and 25% of patients were current smokers. Average office BP (systolic/diastolic) was 154/96 mm Hg, and average 24-hour BP was 136/86 mm Hg. Prevalence of LVH at ECG was 13.9%. The patients who experienced a SCD at follow-up were older (P<0.001), more frequently diabetics (P<0.001) and had a higher office (P=0.002) and ambulatory (P=0.005) systolic BP and PP (all P<0.001), and a higher frequency of ECG LVH (42.4% versus 13.6%, P<0.001) than those who did not experience an SCD.
Results
Over a mean follow-up period of 10.3 years (95% CI, 10.1-10.5), 33 patients developed an SCD. The rate of SCD was 0.10% per year (95% CI, 0.07-0.14) in the total cohort, 0.05 per 100 patient-years (95% CI, 0.04-0.10) in the subset without LVH, and 0.37 100 patient-years (95% CI, 0.18-0.51) in that with LVH. Similarly, it was 0.51 per 100 patient-years (95% CI, 0.30-0.88) and 0.07 per 100 patient-years (95% CI, 0.04-0.10) in those without and with diabetes mellitus.
In unadjusted analyses, both diabetes mellitus (P<0.001) and LVH (P<0.001) were strongly associated with SCD incidence (Figure 2) .
In a multivariable Cox regression model with Firth penalized likelihood, all the above predictors remained significant and independently associated with SCD (Table 2) . Among these predictors, the only modifiable risk factor of proven prognostic relevance was ECG LVH. We, therefore, calculated the adjusted population-attributable fraction associated with ECG LVH, which was 28.2% (95% CI, 17.4%-37.6%).
Among the BP components of proven prognostic relevance (ie, 24-hour systolic BP, 24-hour diastolic BP, 24-hour PP), we selected average 24-hour PP for the final model because it was the only BP component to achieve formal statistical significance (P=0.036). the time-dependent area under the receiver operating characteristic curve at 10 years was 0.85 (95% CI, 0.74-0.96; Figure 3 , right).
Discussion
The novelty of the present study was the identification of a set of predictive factors for SCD in a cohort of initially untreated hypertensive patients without evidence of previous cardiovascular disease. Age, sex, diabetes mellitus, average 24-hour PP, and ECG LVH were independent predictors of SCD. Overall, the predictive model showed an efficient discriminative power between patients with and without future SCD, the time-dependent area under the receiver operating characteristic curve being 0.85. Thus, there was an 85% probability that the 10-year risk of SCD estimated by the above model was higher in randomly selected individuals with future SCD than in those without SCD. 26 The importance of hypertension as a risk factor for SCD is well established. 8, 9, 42 Rapsomaniki et al 8 found that the lifetime risk of SCD at age 30 is about 30% higher in patients with hypertension than in normotensive subjects, and that the risk of SCD rises by 20% for every 20/10 mm Hg increase in BP. Among the potential determinants of SCD in patients with hypertension, the presence of established coronary artery disease plays a dominant role. 20, 43 In a study from Framingham, prior coronary artery disease not only increased the risk of SCD but also modified the associated set of predictive variables, with substantial differences between men and women. 19 Thus, studies conducted in specific subsets of the general population might have the advantage to limit the impact of some confounding factors. In a study from Finland, conducted in a mixed population of patients with and without hypertension and coronary artery disease, each 10 mm Hg increase in systolic and diastolic BP was associated with a significant 15% and 17% higher risk of SCD, respectively, over a follow-up period of 18.9 years. 44 In the present study, we had the opportunity to test for the first time the relation between 24-hour ambulatory BP and the risk of SCD. To our knowledge, previous longitudinal studies which supported the superiority of ambulatory BP over office BP for cardiovascular risk stratification did not address the specific relation between ambulatory BP and SCD. [21] [22] [23] 37, 38, 45, 46 We selected ambulatory PP, instead of systolic or diastolic BP, for inclusion in the multivariable model because it was more informative than other ambulatory BP components. The 24-hour ambulatory BP profile is reported in Figure 4 . For each 10 mm Hg increase in 24-hour ambulatory PP, the risk of SCD increased by 35%. The basic mechanisms of the strong impact of PP on the risk of SCD remain unclear. PP, a marker of stiffness of large elastic arteries, is a well-established determinant of cardiovascular risk in various clinical settings. [47] [48] [49] However, because clinical visits are frequently associated with alerting reactions, 50 office PP might not reflect the usual levels of PP in the single subject. In several studies, a composite pool of cardiovascular events was better predicted by ambulatory PP than by office PP. [35] [36] [37] In a previous study from our group, the risk of coronary artery disease and other cardiac complications of hypertension showed a strong, positive, and independent association with 24-hour ambulatory PP. 38 An abnormally high pulsatile BP component during daily file could thus be viewed as a marker of underlying coronary artery disease even in apparently uncomplicated individuals. Such hypothesis is consistent with the association between 24-hour PP and the risk of SCD noted in the present study.
In the present study, type 2 diabetes mellitus increased the risk of SCD by about 4×. There is ample evidence from literature, although with some exceptions, 51 that type 2 diabetes mellitus confers an increased risk of SCD in the general population, 52 in postmenopausal women, 53 in patients with heart failure, 54, 55 and after myocardial infarction. 56 A general population study found an increased risk of SCD not only in patients with diabetes mellitus but also in subjects with impaired fasting plasma glucose. 57 Several potential mechanisms could explain the higher risk of SCD in type 2 diabetes mellitus. These include an underlying coronary artery disease, 52 a reduced heart rate variability associated with diabetic neuropathy, 58 a QT-interval lengthening and electrophysiological abnormalities, 59, 60 and an enhanced prothrombotic state. 61 The present study extends the available evidence of a direct relationship between LVH and SCD [14] [15] [16] [17] [18] [19] [20] to a relatively young population of patients with hypertension without previous cardiovascular disease. The low risk of SCD in our cohort is reflected by its rate of only 0.10% per year, which is considerably lower than the 0.25% per year in the ARIC study (Atherosclerosis Risk in Communities), 16 0.46% per year in the Cardiovascular Health Study, 16 and 0.16% per year in the Framingham Heart Study.
14 Only few data exist on the risk of SCD in hypertensive populations at low cardiovascular risk. In a small longitudinal study conducted in 59 previously untreated and uncomplicated patients with hypertension who contributed only 6 cases of SCD during follow-up, ECG LVH and a Lown score ≥ were predictors of SCD. 62 In a post hoc analysis of the LIFE study (Losartan Intervention for End Point Reduction), lower timevarying Cornell voltage-duration product and Sokolow-Lyon voltage were associated with a significantly lower risk of SCD after controlling for several potential confounders. 63 The LIFE study is important because it supports, in a large hypertensive population, the continuous relation between improved ECG markers of LVH and reduced risk of SCD. However, the LIFE study has been conducted in a selected cohort of patients with ECG LVH, elevated levels of BP at entry, previous ischemic heart disease in 16%, previous cerebral vascular disease in 8%, and an estimated rate of SCD of about 0.43% per year. 63 Therefore, extrapolation of results to a younger and less complicated hypertensive population requires caution.
The potential arrhythmogenic mechanisms of LVH in hypertensive subjects have been examined in depth. 6, 7, 9 Briefly, LVH may increase the risk of arrhythmias through electrophysiological disturbances, including QT-interval prolongation and dispersion and may be associated with myocardial fibrosis and activation of sympathetic nervous system and renin-angiotensin system. 6, 7, 9 LVH may also predispose to atrial fibrillation, which has been associated with a higher risk of SCD. 64 
Limitations of the Study
The present study should be interpreted within the context of its potential limitations. First, because 100% of our patients were whites, results may not be extrapolated to different ethnic groups. Second, the number of patients with available echocardiographic tracings and noninvasive estimation of large artery properties and subsequent SCD was too small to establish a precise relation between these variables and outcome in our population. Nonetheless, it should be recognized as a stimulus for future research in this area. Finally, the potential impact of incident atrial fibrillation at follow-up as potential mediator of SCD 64 could not be established. Strengths of the present study were the long duration of follow-up and the inclusion of a well-characterized cohort of relatively young patients without prior cardiovascular disease in whom the occurrence of SCD would be a catastrophic outcome.
Conclusions
The present study identified a set of predictive factors for SCD in relatively young and initially untreated patients with hypertension with no evidence of previous cardiovascular disease and overall low risk of dying suddenly. These findings may help in identifying the individuals at higher risk of SCD. Regression of LVH and appropriate management of hypertension should be important priorities in this context.
Perspectives
Although occurrence of SCD would be a catastrophic outcome in relatively young patients with hypertension with no evidence of established cardiovascular disease, predictors of SCD in these individuals remain uncertain. Age, sex, diabetes mellitus, average 24-hour PP and ECG LVH were independent predictors of SCD in our large cohort of relatively young and initially untreated patients with hypertension, without evidence of previous cardiovascular disease, who were followed for an average of 10 years. LVH regression and appropriate BP control should be important priorities in these individuals.
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